Craneware (LON:CRW) Stock Price Passes Above Fifty Day Moving Average – What’s Next?

Craneware plc (LON:CRW) shares passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 1,427.15 and traded as high as GBX 1,473. Craneware shares last traded at GBX 1,470, with a volume of 172,073 shares trading hands.

Wall Street Analysts Forecast Growth

CRW has been the subject of a number of research reports. Berenberg Bank reissued a “buy” rating and issued a GBX 2,900 price target on shares of Craneware in a research report on Tuesday, January 20th. Shore Capital Group restated a “buy” rating and issued a GBX 2,850 price objective on shares of Craneware in a research note on Tuesday, January 20th. Finally, UBS Group restated a “buy” rating and issued a GBX 570 price objective on shares of Craneware in a research note on Wednesday, March 25th. Four equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of GBX 2,297.75.

Craneware Stock Performance

The company has a debt-to-equity ratio of 7.93, a current ratio of 0.76 and a quick ratio of 1.00. The company has a market capitalization of £515.69 million, a price-to-earnings ratio of 23.37 and a beta of 0.28. The business’s 50 day simple moving average is GBX 1,427.15 and its 200 day simple moving average is GBX 1,840.52.

Craneware Company Profile

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.